Sign in

CIK 0001817241 · <br>Emerging growth company

Artiva Biotherapeutics, Inc.

Sign in to watch
Ticker
ARTV
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
863614316
Phone
(858) 267-4467
Business address
5505 MOREHOUSE DRIVE, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,341,159
in 16 filings, $529K under 10b5-1 plans

Net −$2,341,159. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Aslan Fred −$1.8M Chief Executive Officer sold 14% of stake
  2. Horan Christopher −$230K Chief Tech Operations Officer sold 9% of stake
  3. Bush Jennifer −$186K COO, CLO, Compliance Officer sold 7% of stake
  4. Banerjee Subhashis −$128K Chief Medical Officer sold 7% of stake
Date Insider Transaction Shares Price Value Owned after
2024-07-22 venBio Global Strategic Fund III, L.P. 10% owner Conversion · Series A Convertible Preferred Stock −843,592 0
2024-07-22 venBio Global Strategic Fund III, L.P. 10% owner Conversion · Series B Convertible Preferred Stock −214,692 0
2024-07-18 Aslan Fred President and CEO Grant or award · Employee Stock Option (Right to Buy) +343,811 343,811

Page 11 of 11 · 203 trades